FDA Drug · D-0372-2021

Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-142-02.

Class II · Terminated

Presence of foreign substance: identified as activated carbon.

Affected lots / codes — check yours against thisLots #: JKX2749A, JKX2803A, JKX2804A, JKX2805A, JKX806A, JKX2945A,JKX2946A, JXK2947A, JKX2948A, JKX2952A, JKX2953A, JKX2954A & JKX3224A, Exp 6/2032; JKX3211A, JKX3212A, Exp 7/2023.

Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Terminated
Quantity: 50868 bottles
Distribution: USA Nationwide
Recall initiated: May 4, 2021
Classified: May 7, 2021
Terminated: June 27, 2023
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0372-2021%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

See every recall for this brand: Is METFORMIN HYDROCHLORIDE recalled? →

Check this brand across all 8 databases →